Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 25
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Reprod Toxicol ; 47: 59-69, 2014 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-24887032

RESUMO

Toxicology is increasingly focused on molecular events comprising adverse outcome pathways. Atrazine activates the hypothalamic-pituitary adrenal axis, but relationships to gonadal alterations are unknown. We characterized hormone profiles and adrenal (intact and castrate) and testis (intact) proteomes in rats after 3 days of exposure. The adrenal accounted for most of the serum progesterone and all of the corticosterone increases in intact and castrated males. Serum luteinizing hormone, androstenedione, and testosterone in intact males shared a non-monotonic response suggesting transition from an acute stimulatory to a latent inhibitory response to exposure. Eight adrenal proteins were significantly altered with dose. There were unique proteomic changes between the adrenals of intact and castrated males. Six testis proteins in intact males had non-monotonic responses that significantly correlated with serum testosterone. Different dose-response curves for steroids and proteins in the adrenal and testis reveal novel adverse outcome pathways in intact and castrated male rats.


Assuntos
Glândulas Suprarrenais/efeitos dos fármacos , Atrazina/toxicidade , Herbicidas/toxicidade , Testículo/efeitos dos fármacos , Glândulas Suprarrenais/metabolismo , Androstenodiona/sangue , Animais , Atrazina/sangue , Atrazina/farmacocinética , Castração , Corticosterona/sangue , Herbicidas/sangue , Herbicidas/farmacocinética , Hormônio Luteinizante/sangue , Masculino , Progesterona/sangue , Proteoma , Ratos Wistar , Testículo/metabolismo , Testosterona/sangue
2.
Reproduction ; 146(4): 305-14, 2013 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-23847262

RESUMO

Multiple exposures to the herbicide atrazine (ATRZ) were shown to suppress the LH surge in both cycling female rats and those ovariectomized (OVX) and primed with estradiol (E2). A single ATRZ administration was found to induce a prompt and marked increase in progesterone (P4). As exogenous P4 is known to have a differential effect on the LH surge depending on its temporal relationship with the surge, it was hypothesized that a single treatment in an OVX, E2-primed rat would augment the surge, whereas several exposures would cause a decrease. Following four daily treatments with 100 mg/kg, LH surge was suppressed. In contrast, a single ATRZ exposure elevated the surge. Two treatments were without effect. The single administration caused a large increase in P4 at 30 and 60 min that was likely attributable to adrenal secretion. Four exposures also elevated P4 after the final treatment, although the duration of the increase was shortened. A single treatment with 0, 10, 30, and 100 mg/kg ATRZ showed similar elevations at the highest concentration in P4, the LH peak, and area under the curve (AUC), whereas four exposures reduced the AUC. An increase at 1 h in the expression of Kiss1 in the anteroventral periventricular nucleus suggests that this regional kisspeptin neuronal population has a role in the ATRZ augmentation of the surge. These data support the hypothesis that ATRZ-induced changes in adrenal P4 can either augment or attenuate the surge depending on the temporal proximity of exposure to the rise in LH.


Assuntos
Glândulas Suprarrenais/metabolismo , Atrazina/farmacologia , Estrogênios/farmacologia , Hormônio Luteinizante/metabolismo , Ovariectomia , Ovário/efeitos dos fármacos , Progesterona/metabolismo , Animais , Feminino , Herbicidas/farmacologia , Kisspeptinas/genética , Kisspeptinas/metabolismo , Ovário/metabolismo , Ovário/cirurgia , RNA Mensageiro/genética , Ratos , Ratos Long-Evans , Reação em Cadeia da Polimerase em Tempo Real , Reação em Cadeia da Polimerase Via Transcriptase Reversa
3.
Neurotoxicol Teratol ; 34(3): 295-302, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22430068

RESUMO

Previous work has shown that a single oral administration of atrazine (ATR), a chlorotriazine herbicide, causes rapid increases in plasma adrenocorticotropic hormone (ACTH), serum corticosterone (CORT) and progesterone. The mechanism for these effects is unknown. To test whether administration of ATR causes hypothalamic-pituitary-adrenal (HPA) axis activation through the production of a generalized stress response resulting from gastrointestinal distress, we conducted both conditioned taste avoidance (CTA) and pica behavior experiments. Body temperature data were also collected to detect the presence of stress-induced hyperthermia. Adult male Wistar rats were given a single oral dose of ATR (0, 5, 25, 50, 100, or 200 mg/kg) or the primary ATR metabolite diamino-s-chlorotriazine (DACT; 135 mg/kg). Increases were observed in ACTH (LOEL, 12.5 mg/kg), CORT (LOEL, 5 mg/kg) and progesterone (LOEL, 5 mg/kg) 15 min following a single dose of ATR. DACT (135 mg/kg) increased ACTH (1.3-fold), CORT (2.9-fold) and progesterone (1.9-fold) above vehicle control concentrations, but the magnitude of the responses was much lower than that observed for an equal molar dose of ATR (200 mg/kg; 7.0, 9.0 and 11.0-fold above ACTH, CORT, progesterone controls, respectively). CTA results demonstrated conditioned taste avoidance to ATR, with a NOEL of 5 mg/kg. Animals dosed with DACT developed avoidance responses comparable to the highest dose of ATR. In the pica experiment, lower doses (5-50 mg/kg) of ATR had no effect on pica behavior, as measured 6 and 24 h post-dosing, nor did DACT. However, the highest dose of ATR (200 mg/kg) did induce pica behavior at both time points. No differences in body temperature were observed. Overall, results indicate that increases in ACTH and CORT secretion following administration of ATR occur at doses that are without effect on the display of pica behavior, indicating that the HPA-axis activation caused by ATR is not likely the result of gastrointestinal distress.


Assuntos
Atrazina/toxicidade , Comportamento Animal/efeitos dos fármacos , Herbicidas/toxicidade , Sistema Hipotálamo-Hipofisário/efeitos dos fármacos , Pica/induzido quimicamente , Sistema Hipófise-Suprarrenal/efeitos dos fármacos , Paladar/efeitos dos fármacos , Hormônio Adrenocorticotrópico/sangue , Animais , Aprendizagem da Esquiva/efeitos dos fármacos , Condicionamento Psicológico/efeitos dos fármacos , Corticosterona/sangue , Relação Dose-Resposta a Droga , Masculino , Progesterona/sangue , Ratos , Ratos Wistar
4.
Reprod Toxicol ; 32(1): 43-51, 2011 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-21530638

RESUMO

Atrazine (ATR) is an herbicide that exerts negative reproductive effects. We examined the effects of vehicle or ATR (1, 5, 20 and 100mg/kg-d), administered to Sprague-Dawley rats on gestational days 14-21, once daily or divided into two doses per day, on female offspring reproductive indices. Offspring body weights at birth were reduced and mortality increased in the 100mg/kg-d group shortly after birth; by PND 21 there were no significant effects. Vaginal opening was delayed in this group, indicating delayed puberty. No significant differences in mammary gland development were apparent at PND 45, or estrous cyclicity through PND 272. There were no differences between dosing regimens. Lower ATR doses (0-20mg/kg-d) showed few effects in females prenatally exposed to ATR, while the high dose (100mg/kg-d) reduced offspring body weight and delayed vaginal opening. Nonetheless, it is unlikely that environmental exposure comparable to the high dose would be encountered.


Assuntos
Atrazina/toxicidade , Crescimento e Desenvolvimento/efeitos dos fármacos , Herbicidas/toxicidade , Reprodução/efeitos dos fármacos , Animais , Animais Recém-Nascidos , Peso Corporal/efeitos dos fármacos , Perda do Embrião/induzido quimicamente , Ciclo Estral/efeitos dos fármacos , Ciclo Estral/fisiologia , Feminino , Crescimento e Desenvolvimento/fisiologia , Longevidade/efeitos dos fármacos , Glândulas Mamárias Animais/efeitos dos fármacos , Glândulas Mamárias Animais/crescimento & desenvolvimento , Glândulas Mamárias Animais/patologia , Exposição Materna/efeitos adversos , Ratos , Ratos Sprague-Dawley , Reprodução/fisiologia , Maturidade Sexual/efeitos dos fármacos , Maturidade Sexual/fisiologia , Vagina/efeitos dos fármacos , Vagina/crescimento & desenvolvimento
5.
Reprod Toxicol ; 32(1): 52-63, 2011 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-21530639

RESUMO

Few studies have investigated the long-term effects of atrazine (ATR) following in utero exposure. We evaluated the effects of gestational exposure of Sprague Dawley dams to ATR (0, 1, 5, 20, or 100mg/kg-d) on the reproductive development of male offspring. We also quantified the distribution of ATR and its chlorinated metabolites in maternal, fetal, and neonatal fluid and tissue samples following gestational and/or lactational exposure. Dose-dependent levels of chlorotriazines, primarily diamino-s-chlorotriazine, were present in most samples analyzed, including fetal tissue. In utero exposure to 1-20mg/kg-d ATR did not alter testosterone production, the timing of puberty, play behavior, or other androgen-dependent endpoints of male offspring. Significant maternal toxicity and postnatal mortality were observed at 100mg/kg-d. We conclude that, although levels of chlorotriazines within the fetus were considerable, gestational exposures of 1-20mg/kg-d do not lead to alterations in the measures of male development examined in this study.


Assuntos
Atrazina/toxicidade , Desenvolvimento Fetal/efeitos dos fármacos , Feto/efeitos dos fármacos , Genitália Masculina/efeitos dos fármacos , Herbicidas/toxicidade , Reprodução/efeitos dos fármacos , Animais , Animais Recém-Nascidos/crescimento & desenvolvimento , Animais Recém-Nascidos/metabolismo , Atrazina/farmacocinética , Comportamento Animal/efeitos dos fármacos , Comportamento Animal/fisiologia , Feminino , Desenvolvimento Fetal/fisiologia , Feto/embriologia , Feto/metabolismo , Genitália Masculina/embriologia , Genitália Masculina/crescimento & desenvolvimento , Herbicidas/farmacocinética , Masculino , Exposição Materna/efeitos adversos , Ratos , Ratos Sprague-Dawley , Reprodução/fisiologia , Testículo/efeitos dos fármacos , Testículo/metabolismo , Testosterona/metabolismo
6.
Reprod Toxicol ; 31(2): 184-93, 2011 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-21126571

RESUMO

Atrazine (2-chloro-4-ethylamino-6-isopropylamino-s-triazine) was introduced in the 1950s as a broad spectrum herbicide, and remains one of the most widely used herbicides in the United States. Several studies have suggested that atrazine modifies steroidogenesis and may disrupt reproductive function and development in a variety of species. A primary concern has been whether atrazine increases the synthesis of estrogens, perhaps by enhancing aromatase gene expression and activity. In this study, the effect of atrazine was compared in cultures using primary granulosa cells and H295R adrenal cortical carcinoma cells. Atrazine (10 µM), but not its metabolite, 2-chloro-4,6-diamino-1,2,5-triazine (DACT), significantly increased estradiol production and aromatase activity in granulosa cell cultures only when measured for 1-h following 24h of exposure. In H295R cells, atrazine (10 µM) increased estradiol and estrone production. Importantly, atrazine (10 µM) increased progesterone production from both cell types suggesting a broader effect of atrazine on steroidogenesis.


Assuntos
Neoplasias do Córtex Suprarrenal/metabolismo , Atrazina/toxicidade , Hormônios Esteroides Gonadais/biossíntese , Células da Granulosa/efeitos dos fármacos , Herbicidas/toxicidade , Esteroides/biossíntese , Animais , Aromatase/metabolismo , Atrazina/farmacologia , Linhagem Celular Tumoral , Células Cultivadas , Estradiol/biossíntese , Estrona/biossíntese , Feminino , Células da Granulosa/metabolismo , Herbicidas/farmacologia , Progesterona/biossíntese , Ratos
7.
Toxicol Sci ; 112(1): 88-99, 2009 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-19710361

RESUMO

Atrazine (ATR) has recently been shown to activate the hypothalamic-pituitary-adrenal (HPA) axis in rodents. The current study investigated the effect of ATR and two of its chlorinated metabolites, desisopropylatrazine (DIA) and diamino-s-chlorotriazine (DACT), on the HPA axis in the Long-Evans female rat. A single oral gavage administration of 75 mg/kg ATR or 60.2 mg/kg DIA (a dose equimolar to the applied ATR dose) during the morning of proestrus resulted in significant, acute increases in circulating adrenocorticotropic hormone (ACTH), corticosterone, and progesterone. Oral doses of ATR or DIA were given daily over the course of the 4-day ovarian cycle starting on the day of vaginal estrus, resulted in a similar, dose-responsive activation of the HPA axis. The increase in ACTH, corticosterone, and progesterone by these compounds was of a similar magnitude to that produced by 5-min restraint stress. Single or multiple oral exposures to DACT, on the other hand, did not significantly alter pituitary-adrenal hormone release. These results were observed despite plasma levels of DACT being higher than any other metabolite at the time of hormone measurement. Overall, circulating metabolite concentrations following equimolar dosing were much higher than those observed after ATR administration. Additional studies indicated that the activation of the HPA axis by oral exposure to ATR and DIA was not due simply to the stimulation of gastrointestinal afferents. Similar responses were observed in rats which received an oral dose of ATR following bilateral subdiaphramatic vagotomy and following intravenous administration of DIA in jugular vein catheterized animals. We conclude that ATR and the metabolite DIA significantly activate the HPA axis following oral exposure in the female rat. Activation of this endocrine axis by these chlorotriazines could contribute to the induced changes of female reproductive function reported previously.


Assuntos
Atrazina/toxicidade , Herbicidas/toxicidade , Sistema Hipotálamo-Hipofisário/efeitos dos fármacos , Sistema Hipófise-Suprarrenal/efeitos dos fármacos , Administração Oral , Animais , Atrazina/administração & dosagem , Atrazina/metabolismo , Feminino , Herbicidas/administração & dosagem , Herbicidas/metabolismo , Radioimunoensaio , Ratos , Ratos Long-Evans
8.
Reprod Toxicol ; 28(2): 180-7, 2009 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-19409482

RESUMO

A protocol to evaluate the potential developmental and reproductive effects of test chemicals has been developed by the Life Stages Task Force of the International Life Sciences Institute (ILSI)/Health and Environmental Sciences Institute (HESI) Agricultural Chemical Safety Assessment (ACSA) Technical Committee. Since the original publication, several international groups have provided public comment on conducting the test. The extended one-generation reproductive toxicity test is now under consideration as a potential test guideline. The protocol uses a flexible approach that is markedly different from the current multigenerational guidelines. It encourages the use of toxicokinetics when setting the doses, evaluates more than one rat per sex per litter in the F1 offspring and does not necessarily require mating of the F1 to produce an F2 (F1 mating may be triggered by the presence of effects in the P0 and developing F1 rats). A number of additional reproductive endpoints, and the neurotoxicity and immunotoxicity cohorts are included. The ACSA protocol was developed with the goal of assuring that the methods are scientifically appropriate and the toxicological endpoints and exposure durations are relevant for risk assessment. Compared to existing testing strategies, the proposed approach uses substantially fewer animals, provides additional information on the neonate, juvenile and pubertal animal, and includes an estimation of human exposure potential for making decisions about the extent of testing required. In this paper, the evolution of the protocol since the 2006 publication is discussed. These changes reflect the collective input of a U.S. expert panel of government and industrial scientist convened in 2007 and discussions of an OECD expert group held in Paris, France (October, 2008).


Assuntos
Praguicidas/toxicidade , Reprodução/efeitos dos fármacos , Testes de Toxicidade/métodos , Animais , Conferências de Consenso como Assunto , Determinação de Ponto Final/métodos , Feminino , Guias como Assunto , Sistema Imunitário/efeitos dos fármacos , Sistema Imunitário/embriologia , Sistema Imunitário/crescimento & desenvolvimento , Masculino , Sistema Nervoso/efeitos dos fármacos , Sistema Nervoso/embriologia , Sistema Nervoso/crescimento & desenvolvimento , Praguicidas/farmacocinética , Ratos , Reprodução/fisiologia , Medição de Risco
9.
Toxicol Sci ; 107(1): 56-64, 2009 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-18940961

RESUMO

Triclosan (5-chloro-2-(2,4-dichlorophenoxy)phenol) is a potent antibacterial and antifungal compound that is widely used in personal care products, plastics, and fabrics. Recently triclosan has been shown to alter endocrine function in a variety of species. The purpose of this study was to determine effects of triclosan on pubertal development and thyroid hormone concentrations in the male rat. Weanling rats were exposed to 0, 3, 30, 100, 200, or 300 mg/kg of triclosan by oral gavage from postnatal day (PND) 23 to 53. Preputial separation (PPS) was examined beginning on PND 33. Rats were killed on PND 53, organ weights were recorded and serum was collected for subsequent analysis. Triclosan did not affect growth or the onset of PPS. Serum testosterone was significantly decreased at 200 mg/kg, however no effects were observed on androgen-dependent reproductive tissue weights. Triclosan significantly decreased total serum thyroxine (T4) in a dose-dependent manner at 30 mg/kg and higher (no observed effect level of 3 mg/kg). Triiodothyronine (T3) was significantly decreased only at 200 mg/kg, but thyroid stimulating hormone was not statistically different at any dose. Liver weights were significantly increased at 100 mg/kg triclosan and above suggesting that the induction of hepatic enzymes may have contributed to the altered T4 and T3 concentrations, but it does not appear to correlate with the T4 dose-response. This study demonstrates that triclosan exposure does not alter androgen-dependent tissue weights or onset of PPS; however, triclosan exposure significantly impacts thyroid hormone concentrations in the male juvenile rat.


Assuntos
Maturidade Sexual/efeitos dos fármacos , Triclosan/farmacologia , Análise de Variância , Androstenodiona/sangue , Animais , Citocromo P-450 CYP2B1/metabolismo , Relação Dose-Resposta a Droga , Glucuronosiltransferase/metabolismo , Masculino , Microssomos Hepáticos/enzimologia , Ratos , Testículo/anatomia & histologia , Testosterona/sangue , Glândula Tireoide/anatomia & histologia , Tireotropina/sangue , Tiroxina/sangue , Triclosan/administração & dosagem , Tri-Iodotironina/sangue
10.
Toxicol Sci ; 104(1): 107-12, 2008 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-18397915

RESUMO

In female rodents, hypothalamic norepinephrine (NE) has a role in stimulating the secretion of gonadotropin-releasing hormone (GnRH) that triggers the ovulatory surge of luteinizing hormone (LH). NE synthesis from dopamine (DA) is catalyzed by dopamine-beta-hydroxylase (DbetaH) which contains a copper cofactor. Sodium dimethyldithiocarbamate (DMDC) is a pesticide with metal chelating properties that has been found to reduce DbetaH activity. The resultant decrease in NE causes a suppression of both the LH surge and ovulation. The present study examined the dose-related impact of DMDC on hypothalamic GnRH neuronal activation indicated by the nuclear presence of the early gene product c-fos. It represents an essential link between effects on NE and suppression of the surge. Ovariectomized (OVX), estradiol-, and progesterone-primed Sprague-Dawley rats were given a single ip injection of 0, 3.6, 7.1, 14.2, or 28.4 mg/kg DMDC in separate groups of females to assess tissue GnRH/c-fos immunostaining, hypothalamic catecholamines, and serial blood samplings for LH. A dose-related decline in hypothalamic NE and increase in DA at 2 h after DMDC administration were consistent with a decrease in c-fos-positive GnRH neurons, with an almost complete absence of c-fos at the two highest doses. The effects correlated well with a suppression of the surge, although the percentage decrease in c-fos neurons at 7.1 mg/kg only attenuated the surge peak, not the overall amount of circulating LH. The present data offer further evidence that the impact of DMDC on the LH surge is central in origin and in doing so defines the toxic pathway for this effect on ovulation.


Assuntos
Dimetilditiocarbamato/toxicidade , Hormônio Liberador de Gonadotropina/metabolismo , Hipotálamo/efeitos dos fármacos , Hormônio Luteinizante/metabolismo , Neurônios/efeitos dos fármacos , Norepinefrina/metabolismo , Praguicidas/toxicidade , Animais , Feminino , Hipotálamo/metabolismo , Neurônios/metabolismo , Proteínas Proto-Oncogênicas c-fos/metabolismo , Ratos , Ratos Sprague-Dawley
11.
Toxicol Sci ; 100(1): 194-202, 2007 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-17728285

RESUMO

The U.S. Environmental Protection Agency is currently validating assays that will be used in a Tier I Screening Battery to detect endocrine disrupting chemicals. A primary concern with the Protocols for the Assessment of Pubertal Development and Thyroid Function in Juvenile Male and Female Rats is that a nonspecific reduction in body weight (BWT) during the exposure period may potentially confound the interpretation of effects on the endocrine endpoints. Wistar rats were underfed 10, 20, 30, or 40% less than the ad libitum food consumed by controls from postnatal days (PNDs) 22 to 42 (females) or PNDs 23 to 53 (males). Terminal BWT of females and males were 2, 4, 12, and 19% and 2, 6, 9, and 19% lower than controls, respectively. In the females, neither the age of pubertal onset nor any of the thyroid hormone endpoints were affected by food restriction (FR) that led to a 12% decrease in BWT. Similarly, none of the male reproductive endpoints examined were altered by FR that led to a 9% BWT decrease. However, decreased triiodothyronine and thyroxin was observed in FR males with a 9% reduced BWT. While these data support the use of the maximum tolerated dose for BWT (10%) for the female protocol, effects on the male thyroid endpoints indicate that a slightly lower limit (

Assuntos
Peso Corporal/efeitos dos fármacos , Disruptores Endócrinos/toxicidade , Privação de Alimentos , Maturidade Sexual , Testes de Toxicidade/métodos , Redução de Peso , Glândulas Suprarrenais/crescimento & desenvolvimento , Animais , Glicemia/metabolismo , Feminino , Genitália Feminina/crescimento & desenvolvimento , Genitália Masculina/crescimento & desenvolvimento , Rim/crescimento & desenvolvimento , Leptina/sangue , Fígado/crescimento & desenvolvimento , Masculino , Tamanho do Órgão , Hipófise/crescimento & desenvolvimento , Ratos , Ratos Wistar , Reprodutibilidade dos Testes , Glândula Tireoide/crescimento & desenvolvimento , Hormônios Tireóideos/sangue , Testes de Toxicidade/normas , Vagina/crescimento & desenvolvimento
12.
Birth Defects Res B Dev Reprod Toxicol ; 80(2): 98-112, 2007 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-17443714

RESUMO

Atrazine, a chlorotriazine herbicide, is used to control annual grasses and broadleaf weeds. In this review, we summarize our laboratory's work evaluating the neuroendocrine toxicity of atrazine (and related chlorotriazines) from an historic perspective. We provide the rationale for our work as we have endeavored to determine: 1) the underlying reproductive changes leading to the development of mammary gland tumors in the atrazine-exposed female rat; 2) the cascade of physiological events that are responsible for these changes (i.e., the mode of action for mammary tumors); 3) the potential cellular mechanisms involving adverse effects of atrazine; and 4) the range of reproductive alterations associated with this pesticide.


Assuntos
Atrazina/toxicidade , Reprodução/efeitos dos fármacos , Envelhecimento/fisiologia , Animais , Animais Lactentes , Compostos Clorados/toxicidade , Estrogênios/fisiologia , Feminino , Herbicidas/toxicidade , Hipotálamo/efeitos dos fármacos , Hipotálamo/fisiologia , Hormônio Luteinizante/sangue , Neoplasias Mamárias Animais/induzido quimicamente , Ovulação/sangue , Ovulação/efeitos dos fármacos , Hipófise/efeitos dos fármacos , Hipófise/fisiologia , Gravidez , Manutenção da Gravidez/efeitos dos fármacos , Prenhez/efeitos dos fármacos , Prolactina/metabolismo , Ratos , Maturidade Sexual/efeitos dos fármacos
13.
Reprod Toxicol ; 23(4): 607-10, 2007 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-17399945

RESUMO

The purpose of the present study was to examine the distribution of atrazine in the lactating dam and suckling neonate following an acute exposure to either 2 or 4mg/kg 14C-atrazine (14C-ATR) by gavage. 14C-ATR was administered to the nursing dam on postnatal day 3 by oral gavage. Two and a half hours after exposure of the mother to 14C-ATR, the pups were allowed to nurse for 30min. At the end of the nursing period, radiolabelled residues of 14C-ATR [or 14C-chlorotriazines (14C-ClTRI)] were measured in the organs and tissues of the perfused dam and in the stomachs and brains of the rat pups. Both the 2 and the 4mg atrazine treatments resulted in a transfer of approximately 0.007% of 14C-ClTRI to the stomach (indicator of milk content) and 0.0002% to the brains of the offspring following the 30-min nursing period. Three hours following the dose of 14C-ATR, there was a distribution of 14C-ClTRI to the organs of the dam, with the highest amounts in the liver and kidney (1.1 and 0.3% of the administered dose, respectively). Approximately 0.003% of the administered dose was present in three different brain sections of the dam following both doses of 14C-ATR. The results of this study demonstrate that 14C-ClTRI are present in small concentrations in the brain and tissues of the dam (adult female) and provide evidence that atrazine or the metabolites can have direct effects on neuroendrocrine function. The results also provide information for postnatal distribution into the suckling neonate during early lactation.


Assuntos
Atrazina/farmacocinética , Herbicidas/farmacocinética , Lactação , Administração Oral , Animais , Animais Lactentes , Atrazina/administração & dosagem , Atrazina/sangue , Radioisótopos de Carbono/farmacocinética , Relação Dose-Resposta a Droga , Feminino , Herbicidas/administração & dosagem , Herbicidas/sangue , Nível de Efeito Adverso não Observado , Ratos , Ratos Wistar , Medição de Risco , Distribuição Tecidual
14.
Reprod Toxicol ; 23(4): 541-9, 2007 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-17418526

RESUMO

The disinfection by-product dibromoacetic acid (DBA) has been found in female rats to increase circulating concentrations of both estradiol (E2) and estrone (E1). This effect is apparently due, at least in part, to a suppression in hepatic catabolism. The present study investigated whether DBA, by increasing sex steroid levels, is able either to augment the hypothalamic up-regulation involved in triggering a luteinizing hormone (LH) surge, or to affect the ability of the neurotoxicant sodium dimethyldithiocarbamate (DMDC) to block the surge. Sprague-Dawley rats were gavaged for 14 days with DBA (0-150mg/kg) and ovariectomized on dosing day 11, and at the same time implanted with an estradiol capsule to generate daily LH surges. An injection of 0.1mM/kg DMDC was administered at 13:00h on day 14 and blood was sampled over the afternoon. DBA induced a dose-related increase in total estrogens. For identified surges, areas under the LH curve partitioned into two groups, comprising the two lower (0 and 37.5mg/kg DBA) and the two higher (75 and 150mg/kg) treatment groups. Consequently, low and high DBA groups were compared and found to be significantly different. At 150mg DBA/0.1mM DMDC, the timing of an identifiable LH peak was comparable to non-DMDC females, unlike the 37.5mg DBA/0.1mM DMDC group in which the appearance of peak concentrations was delayed. A significant effect with DBA treatment alone was not present. Results indicated that this exposure to DBA induced a dose-related increase in total estrogen concentrations that paralleled a diminished DMDC blockade of the LH surge. The effect appeared to be attributable to an augmentation in the estrogen-associated up-regulation in brain mechanisms stimulating the surge.


Assuntos
Acetatos/toxicidade , Dimetilditiocarbamato/toxicidade , Disruptores Endócrinos/toxicidade , Ciclo Estral/efeitos dos fármacos , Sistema Hipotálamo-Hipofisário/efeitos dos fármacos , Hormônio Luteinizante/sangue , Ovulação/efeitos dos fármacos , Poluentes Químicos da Água/toxicidade , Animais , Relação Dose-Resposta a Droga , Implantes de Medicamento , Estradiol/sangue , Estrogênios/administração & dosagem , Estrogênios/sangue , Estrona/sangue , Ciclo Estral/sangue , Feminino , Sistema Hipotálamo-Hipofisário/metabolismo , Sistema Hipotálamo-Hipofisário/patologia , Norepinefrina/metabolismo , Tamanho do Órgão/efeitos dos fármacos , Ovariectomia , Ovulação/sangue , Adeno-Hipófise/efeitos dos fármacos , Adeno-Hipófise/patologia , Ratos , Ratos Sprague-Dawley , Purificação da Água
15.
Artigo em Inglês | MEDLINE | ID: mdl-17342777

RESUMO

While an evaluation of the estrous cycle in laboratory rodents can be a useful measure of the integrity of the hypothalamic-pituitary-ovarian reproductive axis, it can also serve as a way of insuring that animals exhibiting abnormal cycling patterns are disincluded from a study prior to exposure to a test compound. Assessment of vaginal cytology in regularly cycling animals also provides a means to establish a comparable endocrine milieu for animals at necropsy. The procedure for obtaining a vaginal smear is relatively non-invasive and is one to which animals can become readily accustomed. It requires few supplies, and with some experience the assessments can be easily performed in fresh, unstained smears, or in fixed, stained ones. When incorporated as an adjunct to other endpoint measures, a determination of a female's cycling status can contribute important information about the nature of a toxicant insult to the reproductive system. In doing so, it can help to integrate the data into a more comprehensive mechanistic portrait of the effect, and in terms of risk assessment, may provide some indication of a toxicant's impact on human reproductive physiology.


Assuntos
Ciclo Estral/fisiologia , Roedores/fisiologia , Toxicologia/métodos , Vagina/citologia , Animais , Eutanásia Animal/métodos , Feminino , Humanos , Sistema Hipotálamo-Hipofisário/efeitos dos fármacos , Sistema Hipotálamo-Hipofisário/fisiologia , Queratinas/metabolismo , Modelos Biológicos , Ovário/efeitos dos fármacos , Ovário/fisiologia , Medição de Risco , Comportamento Sexual Animal/efeitos dos fármacos , Testes de Toxicidade/métodos , Vagina/efeitos dos fármacos , Vagina/metabolismo , Esfregaço Vaginal/métodos
16.
Neurotoxicol Teratol ; 29(3): 368-76, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-17258889

RESUMO

Metam sodium (MS) is a soil fumigant and Category II pesticide with a relatively low toxicity in mammals. Previous data have shown an ability to impair reproductive mechanisms in ovariectomized, estradiol-primed rats. A single i.p. injection blocked the luteinizing hormone (LH) surge that in gonadal-intact females initiates the final stages of follicular and oocytic maturation and serves as the trigger for ovulation. The effect paralleled a fall in hypothalamic norepinephrine (NE) and rise in hypothalamic dopamine (DA) that was likely due to a suppression in dopamine-beta-hydroxylase activity. In addition to determining the influence on catecholamine (CA) concentrations from a single oral exposure to MS, the present study explored effects of longer, 3-week treatments on estrous cyclicity, the LH surge, ovulation and hypothalamic CAs. Normally cycling 90 d S-D rats were administered MS (0-200 mg/kg/d, oral) and cyclicity was monitored daily. At the end of the 3rd week, proestrous blood was sampled over the afternoon from regular 4-day cyclers for a determination of LH. These animals were then killed on the following day of estrus (treatment days 21-26) for oocyte retrieval and assessment of hypothalamic CAs. Results showed that shortly after treatment began there occurred a dose-related period of persistent diestrus that typically lasted 8-16 d before regular cycles were reinstated. After 3 weeks, no effects were seen on the magnitude/timing of the LH surge or ovulated oocyte numbers. Anterior and posterior hypothalamic NE and DA were not significantly different from controls, although DA turnover (reflected by the ratio of DOPAC {3,4-dihydroxy-phenylacetic acid} to DA) in both anterior hypothalamic and caudate regions was decreased at all dosages. The data indicate that a 3 week oral exposure to MS induced an initial period of extended diestrus before the resumption of apparently normal reproductive activity, with previously reported CA alterations (apart from a persistent alteration in the DOPAC/DA ratio) being normalized by the end of dosing.


Assuntos
Catecolaminas/metabolismo , Hipotálamo/efeitos dos fármacos , Hipotálamo/metabolismo , Praguicidas/toxicidade , Reprodução/efeitos dos fármacos , Tiocarbamatos/toxicidade , Ácido 3,4-Di-Hidroxifenilacético/metabolismo , Animais , Núcleo Caudado/efeitos dos fármacos , Núcleo Caudado/metabolismo , Dopamina/metabolismo , Relação Dose-Resposta a Droga , Ciclo Estral/efeitos dos fármacos , Feminino , Hormônio Luteinizante/sangue , Norepinefrina/metabolismo , Oócitos/efeitos dos fármacos , Ratos , Ratos Sprague-Dawley
17.
Toxicol Sci ; 94(1): 46-56, 2006 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-16940337

RESUMO

This study was conducted to characterize the estrogen receptor (ER)-binding affinities of 50 chemicals selected from among the high production volume chemicals under the U.S. EPA's (U.S. Environmental Protection Agency's) Toxic Substances Control Act inventory. The chemicals were evaluated using the rat uterine cytosolic (RUC) ER-competitive binding assay, with secondary analysis using Lineweaver-Burk plots and slope replots to confirm true competitive inhibition and to determine an experimental K(i). Data from these ER-competitive binding assays represent the types of competitive binding curves that can be obtained when screening chemicals with broad structural diversity. True competitive inhibition was observed in 17 of 50 chemicals. Binding affinities were much lower than that of estradiol (E(2)) with K(i) concentrations ranging from 0.6 to 373 microM as compared with that of E(2) (0.77 nM). Other chemicals that appeared to displace radiolabeled E(2) binding to ER were, in fact, found not to be competitive inhibitors in the secondary K(i) experiments. These seven chemicals likely altered the stability of the assay by changing the buffer pH, denaturing ER, or disrupting the ER-binding kinetics. Thus, several conditions that may confound interpretation of RUC ER-binding assay data are illustrated. For another group of eight chemicals, neither an IC(50) nor K(i) could be determined due to solubility constraints. These chemicals exhibited slight (20-40%) inhibition at concentrations of 10-100 microM, suggesting that they could be competitors at very high concentrations, yet K(i) experiments were not possible as the limit of chemical solubility in the aqueous assay buffer was well above the IC(50). An additional 18 of the 50 chemicals were classified as nonbinders because in concentrations up to 100 microM they produced essentially no displacement of radiolabeled E(2). These results show that although the ER-competitive binding assay is a valuable tool for screening chemicals, secondary tests such as a double reciprocal Lineweaver-Burk experiment with slope replot should be used to confirm true competitive inhibition. This information will be useful for the ongoing validation of the RUC ER-competitive binding assay under the U.S. EPA's Endocrine Disruptor Screening Program, as well as to support research efforts to develop computational models designed to identify chemicals with the ability to bind to ER.


Assuntos
Substâncias Perigosas/metabolismo , Receptores de Estrogênio/metabolismo , Animais , Ligação Competitiva , Citosol/química , Citosol/metabolismo , Feminino , Cinética , Estrutura Molecular , Ratos , Relação Estrutura-Atividade , Útero/química , Útero/metabolismo
18.
Crit Rev Toxicol ; 36(1): 1-7, 2006 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-16708692

RESUMO

Better understanding of toxicological mechanisms, enhanced testing capabilities, and demands for more sophisticated data for safety and health risk assessment have generated international interest in improving the current testing paradigm for agricultural chemicals. To address this need, the ILSI Health and Environmental Sciences Institute convened a large and diverse group of international experts to develop a credible and viable testing approach that includes scientifically appropriate studies that are necessary without being redundant, and that emphasize toxicological endpoints and exposure durations that are relevant for risk assessment. Benefits of the proposed approach include improved data for risk assessment, greater efficiency, use of fewer animals, and better use of resources. From the outset of this endeavor, it was unanimously agreed that a tiered approach should be designed to incorporate existing knowledge on the chemistry, toxicology, and actual human exposure scenarios of the compound, with integration of studies on metabolism/kinetics, life stages, and systemic toxicities. Three international task forces were charged with designing study types and endpoints on metabolism/kinetics, life stages, and systemic toxicities to be used in the tiered approach. This tiered testing proposal departs from the current standardized list of hazard studies used by many national authorities, and represents the first comprehensive effort of its kind to scientifically redesign the testing framework for agricultural chemicals.


Assuntos
Agroquímicos/toxicidade , Gestão da Segurança , Humanos , Medição de Risco
19.
Crit Rev Toxicol ; 36(1): 69-98, 2006 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-16708695

RESUMO

A proposal has been developed by the Agricultural Chemical Safety Assessment (ACSA) Technical Committee of the ILSI Health and Environmental Sciences Institute (HESI) for an improved approach to assessing the safety of crop protection chemicals. The goal is to ensure that studies are scientifically appropriate and necessary without being redundant, and that tests emphasize toxicological endpoints and exposure durations that are relevant for risk assessment. The ACSA Life Stages Task Force proposes a tiered approach to toxicity testing that assesses a compound's potential to cause adverse effects on reproduction, and that assesses the nature and severity of effects during development and adolescence, with consideration of the sensitivity of the elderly. While incorporating many features from current guideline studies, the proposed approach includes a novel rat reproduction and developmental study with enhanced endpoints and a rabbit development study. All available data, including toxicokinetics, ADME data, and systemic toxicity information, are considered in the design and interpretation of studies. Compared to existing testing strategies, the proposed approach uses fewer animals, provides information on the young animal, and includes an estimation of human exposure potential for making decisions about the extent of testing required.


Assuntos
Agroquímicos/toxicidade , Gestão da Segurança , Animais , Humanos , Reprodução/efeitos dos fármacos , Testes de Toxicidade/métodos
20.
Toxicol Sci ; 84(1): 38-48, 2005 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-15601673

RESUMO

Molinate, a thiocarbamate herbicide, has been reported to impair reproductive capability in the male rat and alter pregnancy outcome in a two-generation study. Published data are lacking on the effects of acute exposure to molinate in the female. Based on this work and our previous observations with related dithiocarbamate compounds, we hypothesized that a single exposure to molinate during the critical window for the neural trigger of ovulation on the day of proestrus (PRO) would block the luteinizing hormone (LH) surge and delay ovulation. To examine the effect of molinate on the LH surge, ovariectomized (OVX) rats were implanted with Silastic capsules containing estradiol benzoate to mimic physiological levels on proestrus. Doses of 25 and 50 mg/kg molinate significantly suppressed LH and prolactin secretion. Intact regularly cycling females gavaged with 0, 25, or 50 mg/kg molinate at 1300 h on PRO were examined on estrus or estrus +1 day for the presence of oocytes in the oviduct. All control females had oocytes in the oviduct on estrus. Molinate doses of 6.25 to 50 mg/kg delayed ovulation for 24 h. Estrous cyclicity was examined after daily exposure to 50 mg/kg (21 days). Estrous cyclicity was irregular in the molinate group, showing extended days in estrus. Two experiments were conducted to determine whether molinate blocked the LH surge via a central nervous system (CNS) mode of action or via an alteration in pituitary response. In the first experiment, we evaluated the release of LH in control and molinate-treated rats after a bolus dose of exogenous GnRH. Luteinizing hormone release was comparable in the two groups, suggesting that the effect of molinate is centrally mediated. To further examine the potential role of the CNS, we examined the pulsatile release of LH present in the long-term OVX females. In this model, the pulsatile pattern of LH secretion is directly correlated with GnRH release from the hypothalamus. A significant decrease in the LH pulse frequency was observed in molinate-treated females. These results indicate that molinate is able to delay ovulation by suppressing the LH surge on the day of proestrus and that the brain is the primary target site for the effects on pituitary hormone secretion.


Assuntos
Azepinas/toxicidade , Herbicidas/toxicidade , Sistemas Neurossecretores/efeitos dos fármacos , Ovulação/efeitos dos fármacos , Tiocarbamatos/toxicidade , Animais , Encéfalo/enzimologia , Colinesterases/sangue , Colinesterases/metabolismo , Dopamina/metabolismo , Relação Dose-Resposta a Droga , Implantes de Medicamento , Estrogênios/administração & dosagem , Estrogênios/farmacologia , Ciclo Estral/efeitos dos fármacos , Feminino , Hormônio Liberador de Gonadotropina/metabolismo , Hipotálamo/metabolismo , Hormônio Luteinizante/sangue , Norepinefrina/metabolismo , Ovariectomia , Hipófise/metabolismo , Gravidez , Prolactina/sangue , Ratos , Ratos Long-Evans , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...